Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
4,395
Period ended Jun 30, 2026
Change on a year earlier
+23.6%
3,557 in Q2 2025
History
68 quarters
Since Q2 2008
Sources
56
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cost of Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 4,395 | +23.6% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,195 | +22.7% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 5,551 | +45.0% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 3,855 | -5.5% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,557 | -5.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,419 | -3.4% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,828 | -2.1% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 4,080 | -4.3% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,745 | -6.9% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,540 | -9.8% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,912 | +0.8% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 4,264 | +8.4% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 4,024 | -4.6% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 3,926 | -27.0% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 3,881 | +0.2% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 3,934 | +14.0% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,216 | +35.8% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 5,380 | +68.2% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 3,874 | -23.0% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 3,450 | +14.5% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 3,104 | +13.0% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 3,199 | -3.4% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,029 | +219.7% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 3,013 | -24.5% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,747 | -19.2% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2020 | Mar 31, 2020 | 3,312 | +8.5% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,573 | -52.2% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 3,990 | +10.3% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,401 | -0.5% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 3,052 | -4.1% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,289 | -4.4% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 3,619 | +9.4% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 3,417 | +9.7% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 3,184 | +4.4% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 3,440 | -0.9% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 3,307 | -3.0% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2017 | Jun 30, 2017 | 3,116 | -12.9% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 3,049 | -14.6% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2016 | Dec 31, 2016 | 3,471 | -9.8% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 3,409 | -9.4% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 3,578 | -4.7% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 3,572 | +0.1% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 3,850 | +2.7% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | 3,761 | -10.9% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 3,754 | -23.3% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 3,569 | -8.6% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 3,749 | – | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 4,223 | -49.7% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 4,893 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 3,903 | -1.4% | Form 10-Q (filed 2014-05-08) ↗ |
| Q2 2013 | Sep 30, 2013 | 8,388 | +102.8% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 3,959 | -1.9% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 4,160 | -0.4% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 4,137 | -4.9% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 4,112 | – | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 4,037 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 4,176 | -5.9% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 4,352 | +3.8% | Form 10-Q (filed 2011-11-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 4,440 | -9.4% | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | 4,191 | +193.0% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 4,549 | +236.0% | Form 10-Q (filed 2011-08-08) ↗ |
| Q1 2010 | Mar 31, 2010 | 5,216 | +291.1% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2009 | Dec 31, 2009 | 4,901 | – | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 1,430 | -17.7% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 1,354 | -29.0% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | 1,334 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q3 2008 | Sep 30, 2008 | 1,737 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2008 | Jun 30, 2008 | 1,908 | – | Form 10-Q (filed 2009-07-24) ↗ |
Cite this data
StockData. (2026). Merck Cost of Sales ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_cor
See every metric in the Merck KPI table. Data updated Oct 26, 2026.